Results 61 to 70 of about 410,020 (135)

Safety of sulfamethoxazole–trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta‐analysis with active comparator disproportionality analysis

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 6, Page 1632-1648, June 2025.
Aims Sulfamethoxazole–trimethoprim (SMX‐TMP) is a widely used antibiotic for treating bacterial infections, but its safety in adult outpatients remains understudied. This systematic review and meta‐analysis evaluated the safety profile of SMX‐TMP and identified critical research gaps.
Rebecca Preyra   +4 more
wiley   +1 more source

Novel Metronidazole Conjugates as Antimicrobial Agents

open access: yesDrug Development Research, Volume 86, Issue 4, June 2025.
ABSTRACT Metronidazole (MTZ) is one of the oldest and still used anti‐infective nitroimidazole group drug. Although it is effective against anaerobic bacteria, protozoa, and parasites in clinical settings, it lacks efficacy against aerobic microorganisms.
Erol Akgün   +4 more
wiley   +1 more source

Oxidative Stress in Antigen Processing and Presentation

open access: yesMedComm – Oncology, Volume 4, Issue 2, June 2025.
Reactive oxygen species (ROS) play a crucial role in antigen processing and presentation, essential for linking innate and adaptive immunity. While balanced ROS levels promote immune function, excess ROS can disrupt antigen recognition, resulting in immune dysfunction.
Qinxia Chang   +9 more
wiley   +1 more source

5-Nitrofuran-Tagged Oxazolyl Pyrazolopiperidines: Synthesis and Activity against ESKAPE Pathogens

open access: yes, 2023
A series of eight 5-nitrofuran-tagged oxazolyl tetrahydropyrazolopyridines (THPPs) has been prepared in six stages with excellent regioselectivity.
Maxim Gureev   +7 more
core   +1 more source

Systematic Review on 1,2,3‐Oxadiazoles, 1,2,4‐Oxadiazoles, and 1,2,5‐Oxadiazoles in the Antimycobacterial Drug Discovery

open access: yesChemMedChem, Volume 20, Issue 9, May 5, 2025.
The review focuses on relationships of oxadiazole derivative structures and their antimycobacterial activity including target structures in mycobacteria, in vitro or in vivo pharmacokinetic parameters, and toxicity. Apart from direct antimycobacterial activity, some 1,2,4‐oxadiazole derivatives can potentiate the antimycobacterial effect of ethionamide
Marta Kučerová‐Chlupáčová
wiley   +1 more source

Development and validation of a new method for determining nitrofuran metabolites in bovine urine using liquid chromatography - tandem mass spectrometry [PDF]

open access: yes, 2013
Background. The use of nitrofurans as veterinary drugs in food-producing animals is banned throughout the European Union. Nevertheless, nitrofuran metabolites have been detected not only in animal products, but also in bovine urine.
Zawadzka, I., Rodziewicz, L.
core  

Development of Antibodies and Immunoassays for Monitoring of Nitrofuran Antibiotics in the Food Chain [PDF]

open access: yes, 2017
Nitrofurans are a broad group of drugs once widely used for the treatment of microbial and proto-zoal infections in many livestock species. However, as concerns grew globally with regard to the potentially carcinogenic and mutagenic effects of their ...
Katrina Campbell   +7 more
core   +1 more source

Determination of nitrofuran residues in milk by LC/MS/MS and assessment of human health risks in Ankara region, Turkey [PDF]

open access: yes
In this study, we investigated the occurrence of nitrofuran (NF) metabolites, namely 3-amino-2-oxazolidinone (AOZ), semicarbazide (SEM), 5-methylmorpholino-3-amino-2-oxazolidinone (AMOZ), and 1-aminohydantoin (AHD), in raw cow's milk and assessed the ...
Ince, S., Ozdemir, O.
core   +1 more source

Home - About - Disclaimer - Privacy